↓ Skip to main content

Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa

Overview of attention for article published in Journal of Antimicrobial Chemotherapy (JAC), July 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs
1 blog
twitter
18 X users

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa
Published in
Journal of Antimicrobial Chemotherapy (JAC), July 2022
DOI 10.1093/jac/dkac241
Pubmed ID
Authors

Cristina Lasarte-Monterrubio, Pablo Arturo Fraile-Ribot, Juan Carlos Vázquez-Ucha, Gabriel Cabot, Paula Guijarro-Sánchez, Isaac Alonso-García, Soraya Rumbo-Feal, Fátima Galán-Sánchez, Alejandro Beceiro, Jorge Arca-Suárez, Antonio Oliver, Germán Bou

X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 17%
Other 4 11%
Researcher 4 11%
Lecturer 1 3%
Student > Bachelor 1 3%
Other 3 8%
Unknown 17 47%
Readers by discipline Count As %
Medicine and Dentistry 5 14%
Biochemistry, Genetics and Molecular Biology 3 8%
Immunology and Microbiology 3 8%
Chemistry 2 6%
Nursing and Health Professions 1 3%
Other 2 6%
Unknown 20 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2023.
All research outputs
#2,065,269
of 25,753,031 outputs
Outputs from Journal of Antimicrobial Chemotherapy (JAC)
#672
of 8,227 outputs
Outputs of similar age
#43,969
of 433,953 outputs
Outputs of similar age from Journal of Antimicrobial Chemotherapy (JAC)
#11
of 89 outputs
Altmetric has tracked 25,753,031 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,227 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,953 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.